A study conducted by Serio and colleagues demonstrated that human iPSCs-derived astrocytes obtained from ALS patients with TDP-43 mutations significantly impaired the subcellular localization of TDP-43 and decreased cell survival ([43]; Table 1). Here, TARDBP is linked to amyotrophic lateral sclerosis.